You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Eye Care (Retinopathy) Articles
Popular Eye Care (Retinopathy) Articles
Highly Recommended Eye Care (Retinopathy) Articles
Arxxant
On April 20, 2006, Eli Lilly & Co. told Diabetes Health that the U.S. Food and Drug Administration has granted priority review status for Arxxant, its potential “first-in-class treatment” for diabetic retinopathy.
Diabetic retinopathy is a result of damage to the small blood vessels in the back of the eye caused by diabetes. According to Eli Lilly, about 40 to 45 percent of Americans diagnosed with diabetes have some stage of diabetic retinopathy, which can lead to vision loss and blindness.
“Currently, there are no approved prescription products to treat diabetic retinopathy, says Eli Lilly. “Arxxant has the potential to represent a significant improvement in the treatment of diabetic retinopathy.”
Categories: Diabetes, Diabetes, Eye Care (Retinopathy), Food, Medications
Jul 1, 2006
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.



Email to a Friend
Send a link to this page to your friends and colleagues.